Plain-English translation of NCT05984875 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects tumor tissue, blood, and other biological samples from women with newly diagnosed ovarian cancer. Researchers want to understand how your immune system responds to ovarian cancer and whether certain immune patterns can predict how well you'll respond to treatment. By studying these patterns, scientists hope to eventually develop better, more personalized treatments for ovarian cancer.
Currently, doctors cannot easily predict which ovarian cancer patients will benefit most from different treatment approaches. This research aims to identify immune system markers that could help doctors choose the best treatment plan for each patient and potentially lead to new therapies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be placed into one of five groups based on your cancer type and planned treatment. You will be asked to provide biological samples at specific time points, including tumor tissue from surgery, blood samples, and swabs from your rectum and vagina. You may also provide fluid from your abdomen if it is present. Your participation involves providing these samples as part of your standard cancer care — the study does not add extra surgeries, but rather uses samples already being collected.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Switzerland